| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615701 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 23 Pages |
Abstract
VCR is effective in MCL and iNHL. Although hematologic toxicity can be an issue, this study demonstrates a high response rate to a novel combination and provides an alternative option in transplant-ineligible R/R MCL and iNHL.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Soham D. Puvvada, José Guillen-Rodriguez, Abhijeet Kumar, Lora Inclán, Kara Heard, Xavier I. Rivera, Faiz Anwer, Jonathan H. Schatz, Daruka Mahadevan, Daniel O. Persky,